Biotechnology Source
Full-Text Research for Life Sciences, Pharma & MedTech
Accelerate discovery and decision-making with Biotechnology Source, the premier research database built for life sciences, pharmaceutical, and medical technology organizations. Access more than 8,700 full-text journals, industry publications, and conference proceedings to support R&D teams and medical affairs professionals with the evidence they need to advance innovation, strengthen communications, and ensure compliance.
Why Choose Biotechnology Source?
Comprehensive Coverage
The world’s largest collection of full-text research indexed in MEDLINE, EMBASE, and BIOSIS, alongside trade publications and global market insights across biotechnology, pharmaceuticals, medical devices, and regulatory science.
Optimized for Research Workflows
Locate precise evidence faster with AI article summaries, citation lookups, and natural language search—plus tools to save searches, export results, create project folders, and set alerts for ongoing discovery.
For R&D and Medical Affairs
Whether you’re conducting literature reviews, preparing regulatory submissions, or monitoring competitor activity, Biotechnology Source supports:
- R&D Teams: Streamline discovery, uncover insights from niche biotech fields, and ensure literature reviews are comprehensive.
- Medical Affairs: Strengthen scientific communications, support publication strategies, and build trusted relationships with KOLs and HCPs using credible, peer-reviewed sources.
Key Features
- 8,700+ full-text journals — including leading titles indexed in MEDLINE, EMBASE, and BIOSIS
- Extensive backfiles — archival content for longitudinal research and trend analysis
- Global coverage — North America, Europe, and Asia with multi-language sources
- Seamless integration — export to research management tools and citation workflows
Supporting Better Decisions Across Teams
Biotechnology Source unifies discovery, collaboration, and compliance in a single platform. Researchers and medical affairs teams can reduce time spent searching, prepare systematic reviews, track competitor pipelines, and support regulatory readiness—all with confidence in the evidence they rely on.